MiNK Therapeutics (INKT) Q2 2025 Earnings

15MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.8
-0.56
-0.31
-0.07

Details

Expected EPS
-0.6077
Actual EPS
-0.7
Surprise EPS
-0.09
Surprise Percent
+15.19%

Description

MiNK Therapeutics (INKT) has reported earnings of -0.7 per share for Q2 2025.

0 Comments

Share your thoughts